Dextrorphan-derivatives with suppressed central nervous activity

US10464904B2 · kind B2 · utility

Assignee

• Heinrich-Heine-Universitat Dusseldorf · DE

Inventors

• Eckhard Lammert · Mülheim an der Ruhr, DE
• Alena Welters · Neunburg vorm Wald, DE
• Silke Otter · Duisburg, DE
• Jan Marquard · Mainz, DE
• Thomas Meissner
• Diran Herebian · Düsseldorf, DE
• Ertan Mayatepek · Düsseldorf, DE

Key dates

• Filing date: Dec 2, 2016
• Grant date: Nov 5, 2019
• Expiry date: Dec 2, 2036

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D401/04
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The invention relates to dextrorphan-derivatives, pharmaceutical compositions and pharmaceutical dosage forms containing such dextrorphan-derivatives as well as the use of those dextrorphan-derivatives and/or compositions for treating and preventing diseases and conditions in man and mammals.